Silk Road Medical, Inc (NASDAQ:SILK) Receives Consensus Rating of "Hold" from Brokerages theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Silk Road Medical (NASDAQ:SILK – Free Report) had its price target lifted by JPMorgan Chase & Co. from $19.00 to $21.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm currently has a neutral rating on the stock. Several other equities analysts also recently weighed in on SILK. Stifel Nicolaus raised […]
Silk Road Medical (NASDAQ:SILK – Get Free Report) posted its quarterly earnings results on Tuesday. The company reported ($0.36) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.40) by $0.04, Briefing.com reports. Silk Road Medical had a negative net margin of 31.70% and a negative return on equity of 36.38%. The company […]
Silk Road Medical (NASDAQ:SILK) Posts Earnings Results, Beats Estimates By $0.04 EPS theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Several analysts have recently updated their ratings and price targets for Silk Road Medical (NASDAQ: SILK): 10/24/2023 – Silk Road Medical was upgraded by analysts at Wolfe Research from an “underperform” rating to a “peer perform” rating. 10/11/2023 – Silk Road Medical was downgraded by analysts at Citigroup Inc. from a “buy” rating to a […]